Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models

  1. Bargiela, A.
  2. Sabater-Arcis, M.
  3. Espinosa-Espinosa, J.
  4. Zulaica, M.
  5. De Munain, A.L.
  6. Artero, R.
Zeitschrift:
Proceedings of the National Academy of Sciences of the United States of America

ISSN: 1091-6490,  0027-8424

Datum der Publikation: 2019

Ausgabe: 116

Nummer: 50

Seiten: 25203-25213

Art: Artikel

DOI: 10.1073/PNAS.1820297116 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus